Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.

Source:http://linkedlifedata.com/resource/pubmed/id/10423466

N. Engl. J. Med. 1999 Jul 29 341 5 319-27

Download in:

View as

General Info

PMID
10423466